Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003753
What this trial is testing

Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Testing effectiveness (Phase 2)Study completedNCT00025350
What this trial is testing

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003950
What this trial is testing

Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 16
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Not applicableStudy completedNCT05225870
What this trial is testing

Significance of Cortactin Expression in Colorectal Adenocarcinomas

Who this might be right for
Cancer Colon
Sohag University 50
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Not applicableActive Not RecruitingNCT04684862
What this trial is testing

Infusion System for Hepatic Cancer

Who this might be right for
Colorectal Cancer Metastatic to LiverIntrahepatic Cholangiocarcinoma
Ronald DeMatteo, M.D. 100
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT02599324
What this trial is testing

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Urothelial CarcinomaAdvanced Gastric Adenocarcinoma+1 more
Pharmacyclics LLC. 263
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Not applicableStudy completedNCT05513183
What this trial is testing

Severe Neutropenia After HIPEC Using Mitomycin-C

Who this might be right for
Colorectal Cancer MetastaticCancer Metastatic to the Peritoneal CavityAppendiceal Neoplasm+1 more
Gangnam Severance Hospital 74
Early research (Phase 1)Looking for participantsNCT07348211
What this trial is testing

First in Human Study of SIM0610 in Solid Tumors

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT01177007
What this trial is testing

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Who this might be right for
Liver Neoplasms
Yale University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02758951
What this trial is testing

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Who this might be right for
Colorectal NeoplasmColorectal CancerColorectal Neoplasms Malignant+8 more
Koen Rovers 358
Early research (Phase 1)WithdrawnNCT04799431
What this trial is testing

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Cancer MetastaticColorectal Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT05039177
What this trial is testing

ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma
Erasca, Inc. 101
Testing effectiveness (Phase 2)Ended earlyNCT00004193
What this trial is testing

ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07815834
What this trial is testing

FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)

Who this might be right for
Colon Rectal Cancer AdenocarcinomaPeritoneal (Metastatic) CancerSecond-line Treatment+2 more
Fudan University 198
Next Page